Advertisement

Topics

Bard Peripheral Vascular OEM Products Company Profile

16:09 EDT 20th June 2019 | BioPortfolio


News Articles [891 Associated News Articles listed on BioPortfolio]

AngioDynamics to Present at the Needham Healthcare Conference

AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today...

AngioDynamics to Present at the Raymond James Life Sciences and MedTech Conference

AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today...

FDA approves Intact Vascular’s Tack Endovascular System

Intact Vascular, Inc., a private medical device company committed to developing solutions for minimally invasive peripheral vascular procedures, today announced it received U.S. Food and Drug Administ...

AngioDynamics to Present at the Barclays Global Healthcare Conference

AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today...

C. R. Bard, Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 05122018] Prices from USD $175

C. R. Bard, Inc. Strategy, SWOT and Corporate Finance ReportSummaryC. R. Bard, Inc. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report...

Series D brings in an initial $25mm for Intact Vascular

Intact Vascular Inc. (minimally invasive devices for peripheral vascular procedures) raised $25mm through its Series D financing led by Vensana Capital, which was joined by returning shareholders New ...

NuCryo Vascular launches new extended PolarCath balloon dilatation catheter

NuCryo Vascular said that the PolarCath Peripheral Dilatation System has secured US Food and Drug Administration (FDA) clearance in 2002 to dilate stenosis in the peripheral vasculature including The...

AngioDynamics Wins Patent Infringement Dispute With Bard

AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease and oncology, today annou...

Drugs and Medications [1 Associated Drugs and Medications listed on BioPortfolio]

Cordran [allergan, inc.]

Cordran Tape Flurandrenolide Tape, USP Rx only

PubMed Articles [2834 Associated PubMed Articles listed on BioPortfolio]

Paclitaxel drug-coated balloon angioplasty for the treatment of failing arteriovenous fistulas: a single-center experience.

To report our experience of angioplasty with Lutonix (Bard Peripheral Vascular, Inc., Tempe, AZ) drug-coated balloon (DCB) for the treatment of failing arteriovenous fistulas (AVF).

An elderly patient with severe peripheral vascular disease.

Peripheral arterial disease is a common condition in elderly patients. Cases of severe peripheral vascular disease can be treated with endovascular revascularization or bypass surgery. An amputation m...

Predictors of Peripheral Vascular Injury in Patients with Blunt Lower Extremity Fractures.

Early identification of peripheral vascular injuries is crucial to prevent acute limb ischemia and amputation. We sought to identify predictors of vascular injury in patients with blunt lower extremit...

Perceptions of Canadian vascular surgeons toward pharmacologic risk reduction in patients with peripheral artery disease: 2018 update.

Vascular surgeons have a central role in managing peripheral artery disease (PAD). This study assessed their knowledge, attitudes, and behaviours regarding pharmacologic risk reduction in PAD and resu...

Evaluation of relationships between onychomycosis and vascular diseases using sequential pattern mining.

Onychomycosis (OM) is a common nail disease. Although controversial, vascular diseases are considered independent predictors of OM and vice versa. Sequential pattern mining (SPM) has not been previous...

Clinical Trials [5857 Associated Clinical Trials listed on BioPortfolio]

Utility, Safety, and Effectiveness of the Bard LifeStent 5F Vascular Stent System

The medical device being examined in this study is the Bard® LifeStent® 5F Vascular Stent System. It is intended for use in patients who suffer from peripheral artery disease (PAD). PAD ...

Safety and Efficacy of Midline and PICC

The purpose of this study is to assess the non-inferiority for safety and efficacy of using Midline in comparison with PICC for intravenous therapy that do not require a central catheter.

Study of Drug Eluting Peripheral Vascular Stent System in Superficial Femoral Artery Stenosis and /or Occlusion

Evaluation of drug eluting peripheral vascular stent system for the treatment of superficial femoral artery stenosis and / or occlusion, there is batter in effectiveness and clinical perfo...

The Study to Compare the Cordis SMART™ Stent System With the Bard® Luminexx™ Stent

This study will look at the performance of the Cordis S.M.A.R.T.™ CONTROL ™ Nitinol Stent System for the treatment of TASC C & D superficial femoral artery long lesions (up to 22 cm) i...

Study Of Hernia Repair Utilizing The Bard Ventrio Hernia Patch

This study will collect data on patients undergoing hernia repair using the Bard Ventrio Hernia Patch. The study will evaluate hernia recurrence rates, operating time, quality of life and...

Companies [867 Associated Companies listed on BioPortfolio]

Bard Peripheral Vascular OEM Products

CR Bard

C. R. Bard, Inc. is a leading multinational developer, manufacturer, and marketer of innovative, life-enhancing medical technologies in the fields of Vascular, Urology, Oncology, and Surgical Specialt...

C. R. Bard, Inc

C. R. Bard, Inc. is a leading multinational developer, manufacturer, and marketer of innovative, life-enhancing medical technologies in the fields of Vascular, Urology, Oncology, and Surgical Specialt...

Intact Vascular

Intact Vascular is a privately held medical device company that develops minimally invasive peripheral vascular products. The Tack-It Endovascular Stapler™ is designed to opt...

Intact Vascular, Inc.

Intact Vascular is a privately held medical device company that develops minimally invasive peripheral vascular products. The Tack-It Endovascular Stapler™ is designed to opt...

More Information about "Bard Peripheral Vascular OEM Products" on BioPortfolio

We have published hundreds of Bard Peripheral Vascular OEM Products news stories on BioPortfolio along with dozens of Bard Peripheral Vascular OEM Products Clinical Trials and PubMed Articles about Bard Peripheral Vascular OEM Products for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Bard Peripheral Vascular OEM Products Companies in our database. You can also find out about relevant Bard Peripheral Vascular OEM Products Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record